Why convertibles exist
A priced round requires agreeing on a valuation. For very early-stage companies โ pre-product, pre-revenue, sometimes pre-team โ the question 'what is this company worth?' has no useful answer. Negotiating a valuation in this state is slow, contentious, and produces numbers that are essentially arbitrary.
Convertible instruments sidestep the problem. The investor puts in capital today; the equity is issued later, at the price set by the next priced round. The instrument specifies the conversion mechanics but not the price.
Two categories of convertible instruments dominate.
Convertible notes. Legally a debt instrument. The investor lends money to the company; the note carries an interest rate (typically 4โ8%) and a maturity date (typically 18โ36 months). At the next 'qualified financing' (a priced round above a threshold size), the note converts into the priced-round preferred at a discount and/or with a valuation cap.
SAFEs (Simple Agreement for Future Equity). Introduced by Y Combinator in 2013. Not debt โ a contractual right to future shares. No interest, no maturity. At the next qualified financing, the SAFE converts to preferred shares at a discount and/or valuation cap.
Both instruments are simpler and faster than a priced round: a SAFE is famously about five pages, signed in hours. A priced round involves a term sheet, due diligence, charter amendments, stockholder approvals โ weeks to months. The instrument's simplicity is why most pre-seed and seed funding now flows through them.
